Basaksehir Cam and Sakura City Hospital, Neurosurgery, Istanbul, Turkey.
Basaksehir Cam and Sakura City Hospital, Neurology, Istanbul, Turkey.
Acta Neurochir (Wien). 2024 Sep 16;166(1):369. doi: 10.1007/s00701-024-06257-x.
Speech changes significantly impact the quality of life for Parkinson's disease (PD) patients. Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) is a standard treatment for advanced PD, but its effects on speech remain unclear. This study aimed to investigate the relationship between STN-DBS and speech changes in PD patients using comprehensive clinical assessments and tractography.
Forty-seven PD patients underwent STN-DBS, with preoperative and 3-month postoperative assessments. Speech analyses included acoustic measurements, auditory-perceptual evaluations, and fluency-intelligibility tests. On the other hand, structures within the volume tissue activated (VTA) were identified using MRI and DTI. The clinical and demographic data and structures associated with VTA (Corticospinal tract, Internal capsule, Dentato-rubro-thalamic tract, Medial forebrain bundle, Medial lemniscus, Substantia nigra, Red nucleus) were compared with speech analyses.
The majority of patients (36.2-55.4% good, 29.7-53.1% same) exhibited either improved or unchanged speech quality following STN-DBS. Only a small percentage (8.5-14.9%) experienced deterioration. Older patients and those with worsened motor symptoms postoperatively were more likely to experience negative speech changes (p < 0.05). Interestingly, stimulation of the right Substantia Nigra correlated with improved speech quality (p < 0.05). No significant relationship was found between other structures affected by VTA and speech changes.
This study suggests that STN-DBS does not predominantly negatively impact speech in PD patients, with potential benefits observed, especially in younger patients. These findings underscore the importance of individualized treatment approaches and highlight the need for further long-term studies to optimize therapeutic outcomes and better understand the effects of STN-DBS on speech.
言语变化显著影响帕金森病(PD)患者的生活质量。丘脑底核(STN)深部脑刺激(DBS)是治疗晚期 PD 的标准方法,但它对言语的影响尚不清楚。本研究旨在使用综合临床评估和轨迹分析来研究 STN-DBS 与 PD 患者言语变化之间的关系。
47 例 PD 患者接受了 STN-DBS,术前和术后 3 个月进行评估。言语分析包括声学测量、听觉感知评估和流畅性-可理解性测试。另一方面,使用 MRI 和 DTI 识别 VTA 内的结构。将临床和人口统计学数据以及与 VTA 相关的结构(皮质脊髓束、内囊、齿状红核束、内侧前脑束、内侧丘系、黑质、红核)与言语分析进行比较。
大多数患者(36.2-55.4%为好,29.7-53.1%相同)在接受 STN-DBS 后言语质量得到改善或保持不变。只有一小部分(8.5-14.9%)出现恶化。术后运动症状恶化的老年患者更有可能出现负性言语变化(p<0.05)。有趣的是,右侧黑质的刺激与言语质量的改善相关(p<0.05)。未发现 VTA 受影响的其他结构与言语变化之间存在显著关系。
本研究表明,STN-DBS 不会主要对 PD 患者的言语产生负面影响,观察到潜在的益处,特别是在年轻患者中。这些发现强调了个体化治疗方法的重要性,并突出了需要进一步进行长期研究以优化治疗效果并更好地理解 STN-DBS 对言语的影响。